Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/16/1989 | DE3814806A1 Method for the stabilisation of amino-acid infusion solutions |
11/15/1989 | EP0341961A2 Polymalonic acids as boneaffinity agents |
11/15/1989 | EP0341774A1 Pharmaceutical solutions of triamterene |
11/15/1989 | EP0341745A1 Crosslinked carboxy polysaccharides |
11/15/1989 | EP0341661A2 Peptide-drug compositions containing alpha-aminoboronic acid derivatives |
11/15/1989 | CN1037082A Multi-layer granule |
11/14/1989 | US4880830 Slow release formulation |
11/14/1989 | US4880823 Injection of nicardinpine hydrochloride and process for the production thereof |
11/14/1989 | US4880796 Antimicrobial preparation |
11/14/1989 | US4880774 Sustained release aromatic |
11/14/1989 | US4880636 Storage stability, triacetin plasticizers |
11/14/1989 | US4880635 Dehydrated liposomes |
11/14/1989 | US4880623 Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thus obtained |
11/14/1989 | US4880610 Neutralization, crystallization |
11/14/1989 | US4880563 Cosmetic lotions |
11/09/1989 | DE3913350A1 Acid addition salts from amidated taurine or glycine, their preparation and use |
11/09/1989 | DE3912292A1 Azelastine-containing pharmaceuticals with controlled release of active substance |
11/08/1989 | EP0341126A1 Surfactant compositions based on poly(phenyl-1-ethyl)polyoxyalkyl phosphoric acid esters, their preparation and their use to obtain aqueous dispersions of active material |
11/08/1989 | EP0340289A1 Liquid ibuprofen compositions and methods of making them |
11/07/1989 | USRE33107 Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
11/07/1989 | US4879304 Ophthalmic compositions and process for preparing |
11/07/1989 | US4879303 Besylate salt of amlodipine; antiischemic, hypotensive |
11/07/1989 | US4879297 Transdermal drug delivery |
11/07/1989 | US4879294 Opthalmic composition |
11/07/1989 | US4879286 Anticarcinogenic agents |
11/07/1989 | US4879281 Artificial saliva composition |
11/07/1989 | US4879275 Penetration enhancers for transdermal delivery of systemic agent |
11/07/1989 | US4879274 External medication for skin |
11/07/1989 | US4879272 On walls of container |
11/07/1989 | US4879119 Patch |
11/07/1989 | US4879109 Method for treating burns |
11/07/1989 | CA1262686A1 Composition to alleviate nausea and vomitting |
11/02/1989 | WO1989010348A1 Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof |
11/02/1989 | WO1989010186A1 Lipid composition having enough safety and strong surface activity |
11/02/1989 | WO1989010142A1 Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment |
11/02/1989 | WO1989010140A1 Further improvements relating to drug delivery systems |
11/02/1989 | WO1989010138A1 Physiological active liquid allergenic composition from biological raw materials |
11/02/1989 | WO1989010134A1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
11/02/1989 | WO1989010113A1 Antimicrobial composition with long-term activity |
11/02/1989 | EP0340171A2 Cyclodextrin complexes of 5-aminohexahydropyrimidine compounds |
11/02/1989 | EP0339811A2 Aqueous based pharmaceutical coating composition for dosage forms |
11/02/1989 | EP0339695A2 A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates |
11/02/1989 | EP0339555A2 Water soluble preparations of coccidiostatics |
11/02/1989 | EP0339531A1 Physiological active liquid allergenic composition from biological raw materials |
11/02/1989 | EP0339506A1 Oral osmotic system with a modified adhesion of the membrane to the core |
11/02/1989 | EP0339465A2 Antibacterial composition for oral administration |
11/02/1989 | DE3813015A1 Stable, heat-sterilisable carbamazepine solution for parenteral administration |
11/01/1989 | CN1036793A Monoclonal antibody specific to mucin-like glycoprotein surface antigen on human carcinoma cells |
10/31/1989 | US4877883 Substituted pyrazoles |
10/31/1989 | US4877774 Complexing with gamma-cyclodextrin |
10/31/1989 | US4877608 Sodiuum chloride and-or potassium chloride, lysine hydrochloride, and histidine |
10/31/1989 | US4877606 Freeze dried, stable aqueous dispersion of drug |
10/25/1989 | EP0338978A2 Taste masking of thymol |
10/25/1989 | EP0338946A1 Sweetening agents which derive from the acides l-aspartic and l-glutamotic-n-hydrocarbonés |
10/25/1989 | EP0338916A1 Haemoglobin macromolecular complexes, method of preparation and their uses |
10/25/1989 | EP0338846A2 Monoclonal antibodies |
10/25/1989 | EP0338732A2 Matrix for release of active ingredients |
10/25/1989 | EP0338589A2 Microbicidal cleanser/barrier kit for preventing the transmission of aids and other sexually transmitted diseases |
10/25/1989 | EP0338444A1 Substituted release azelastine containing medicaments |
10/25/1989 | EP0338291A1 Antiinflammatory Gel |
10/25/1989 | CN1036508A Pharmaceutical compositions having good stability |
10/24/1989 | US4876249 Compositions and method comprising heterocyclic compounds containing two heteroatoms |
10/24/1989 | US4876244 Medical composition for injection containing a spergualin as active ingredient and process for preparing the same |
10/24/1989 | US4876097 Ph sensitive |
10/24/1989 | US4876088 Gamma-globulin injectable solutions containing sorbitol |
10/19/1989 | WO1989009833A1 Luminide and macroluminide class of pharmaceuticals |
10/19/1989 | WO1989009800A1 Novel transdermal penetration enhancers |
10/19/1989 | WO1989009624A1 Solubilization of proteins for pharmaceutical compositions |
10/19/1989 | WO1989009614A1 Human growth hormone formulation |
10/19/1989 | WO1989009610A1 Tumor necrosis factor formulations |
10/19/1989 | WO1989009609A1 Solvent system for chronic vascular infusion of hydrophobic drugs |
10/19/1989 | WO1989009595A1 Dithranol-containing pharmaceutical product for flaking skin diseases |
10/18/1989 | EP0337890A1 Complexes from anthralin and one sterol, process for their preparation and their use in therapeutics and cosmetics |
10/18/1989 | EP0337746A2 Composition for enhancing the biodistribution of antibody for localization in lesions |
10/18/1989 | EP0337733A2 Single dose intramuscular treatment of chlamydia trachomatis infections |
10/18/1989 | EP0337289A1 Pharmaceutical composition containing dithranol for the treatment of the skin exfoliative diseases |
10/18/1989 | EP0336957A1 Viscoelastic material for ophthalmic surgery |
10/18/1989 | CN1036327A Preparing method of indomethacinum gel |
10/18/1989 | CN1036326A Method and formulation for orally administering bioactive agents to and through the peyer's patch |
10/17/1989 | US4874850 Pharmaceutical preparations |
10/17/1989 | US4874795 Composition for delivery of orally administered drugs and other substances |
10/17/1989 | US4874605 Stabilized delayed release emulsion |
10/17/1989 | US4874553 Aqueous phospholipid solutions containing a solubilizing agent |
10/17/1989 | CA1262334A1 Steroidal liposomes |
10/12/1989 | EP0304424A4 WATER SOLUBLE COMPLEX OF A POLY(VINYLPYRROLIDONE) COPOLYMER AND -g(a)-METHYL-(2-METHYLPROPYL)BENZENE ACETIC ACID. |
10/12/1989 | EP0262178A4 Amino acid chelated compositions for delivery to specific biological tissue sites. |
10/11/1989 | EP0336902A2 Antiinflammatory skin moisturizing composition and method of preparing same |
10/11/1989 | EP0336901A2 Anesthetic skin moisturizing composition and method of preparing same |
10/11/1989 | EP0336894A1 Sugarless pectin delivery system |
10/11/1989 | EP0336851A1 Pharmaceutical composition for oral administration containing a diphosphonic acid derivative |
10/11/1989 | EP0336817A1 Gel emulsion particles and compositions thereof |
10/11/1989 | EP0336666A2 Polymerised substituted benzoid alkyl sulfonic acids and their salts as efficient protective colloids for microcapsulation systems |
10/11/1989 | EP0336631A2 Improved cytotoxic therapy |
10/11/1989 | EP0336405A2 Anti-human cancer protein complexes, their production and use |
10/11/1989 | EP0336383A2 Novel recombinant human lymphotoxin |
10/11/1989 | EP0336364A2 Modified cellular substrates used as linkers for increased cell retention of diagnostic and therapeutic agents |
10/11/1989 | EP0336298A1 Pharmaceutical compositions having good stability |
10/11/1989 | EP0336000A1 Ambiphilic cream |
10/11/1989 | EP0335982A1 Gelatin composition |
10/11/1989 | EP0335970A1 Tablet for use in the treatment of progesterone deficiency |